Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)
| 19.57 Delayed Data As of Oct 30 |  -0.52 / -2.59%Today’s Change | 12.33 Today|||52-Week Range 22.69 | +1.45% Year-to-Date |
Latest AMPH News | Press Releases
| Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: Should You Buy? Oct 30 / Zacks.com - Paid Partner Content | 3 Reasons Why Growth Investors Shouldn't Overlook Amphastar (AMPH) Oct 23 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 20.09 |
| Today’s open | 19.66 |
| Day’s range | 19.32 - 19.90 |
| Volume | 9,215 |
| Average volume (3 months) | 213,263 |
| Market cap | $927.9M |
Data as of 3:59pm ET, 10/30/2020
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +78.17% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +9.40% |
| P/E ratio | 244.4 |
| Price/Sales | 2.99 |
| Price/Book | 2.39 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ICPTIntercept Pharmaceut... | -1.09 | -3.77% |
| ---- | ||
| SUPNSupernus Pharmaceuti... | -0.01 | -0.05% |
| AKROAkero Therapeutics I... | 0.00 | 0.00% |
Data as of 4:00pm ET, 10/30/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | $0.14 |
| Annual revenue (last year) | $322.4M |
| Annual profit (last year) | $48.9M |
| Net profit margin | 15.18% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Rancho Cucamonga, California |
Forecasts
